PDE5A and early-onset autosomal dominant Alzheimer disease: Dong et al. [75] focused on the PDE5 enzyme as a promising non-beta amyloid-related target for treatment and imaging of Alzheimer’s disease and thus, [11C]19 and [11C]20 were generated to investigate PDE5 in the brain by PET.